DEF 14A: SCWorx Corp. Seeks Stockholder Approval for Multiple Share Issuances and Potential Reverse Stock Split

SCWorx Corp. is seeking stockholder approval for several proposals, including multiple share issuances to satisfy debt and raise capital, and a potential reverse stock split to maintain Nasdaq listing compliance.

Summary

• SCWorx Corp. is holding its annual meeting of stockholders on December 23, 2024, to vote on several key proposals.
• The company is seeking approval to elect four directors to the board.
• Stockholders will also vote on an advisory basis on the compensation of named executive officers.
• A key proposal is to ratify the selection of Astra Audit & Advisory, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The company is seeking approval for multiple share issuances related to convertible notes, warrants, and a settlement agreement, all of which could result in dilution for existing shareholders.
• These issuances are necessary to comply with Nasdaq listing rules, as they involve issuing more than 20% of the company's outstanding common stock at prices below the minimum price.
• The company is also seeking approval for a potential reverse stock split, with a ratio between 1/2 and 1/15, if the stock price falls below $1.00 and the company receives a deficiency notice from Nasdaq.
• The company has entered into a Securities Purchase Agreement on July 16, 2024, selling convertible notes and warrants for $1,155,000, with an initial conversion price of $1.43 per share, which has since been adjusted to $0.86 per share.
• The company also entered into a settlement agreement on July 15, 2024, to issue shares to Core IR to satisfy a judgment of approximately $502,000.
• A private investment on November 19, 2024, resulted in the sale of 232,558 shares and warrants for $200,000.
• The company is planning a second issuance of convertible notes and warrants within 60 days of the annual meeting, with a target of $1 million to $1.5 million.
• The company is seeking approval for all these issuances as they may exceed 20% of the outstanding shares and be at prices below the minimum price.

Sentiment

Score: 3

Explanation: The document indicates significant financial challenges and potential dilution for existing shareholders, leading to a negative sentiment. The company is relying on potentially dilutive financing methods and is facing the risk of delisting, which further contributes to the low score.

Positives

• The company is actively seeking to raise capital through various means, including convertible notes and warrants.
• The company is addressing a legal settlement by issuing shares, which avoids further cash outlays.
• The company is taking steps to maintain its Nasdaq listing by proposing a reverse stock split if necessary.
• The company has a board of directors with experience in healthcare and technology.

Negatives

• The proposed share issuances will significantly dilute existing shareholders' ownership.
• The company is issuing shares at prices below the minimum price, which could further depress the stock price.
• The company is relying on potentially dilutive financing methods to raise capital.
• The company has had to adjust the conversion price of its convertible notes due to anti-dilution provisions.
• The company has had to issue additional shares to Core IR due to a delay in filing the registration statement.

Risks

• The company's stock price could decline due to the issuance of new shares.
• Existing shareholders will experience significant dilution of their ownership.
• The company may not be able to raise sufficient capital if the proposed issuances are not approved.
• The company may face delisting from Nasdaq if it cannot maintain a minimum bid price of $1.00 per share.
• The company's ability to execute its business plan could be jeopardized if it cannot secure additional funding.
• The company is dependent on the exercise of warrants by investors, which is not guaranteed.
• The company has a history of related party transactions, which could raise concerns about conflicts of interest.

Future Outlook

The company plans to execute a second offering of convertible notes and warrants within 60 days of the annual meeting, and may implement a reverse stock split if necessary to maintain Nasdaq listing compliance. The company is also seeking to raise additional capital through the exercise of warrants.

Management Comments

• The Board believes that the Offering was the only viable financing alternative available to us at the time.
• The Board believes effecting the reverse stock split would be an effective means to increase the per share price of the Companys common stock to a minimum of at least $1.00 per share if the companys stock price were to fall below a minimum bid price of $1.00 and would thereby remedy any Nasdaq deficiencies.

Industry Context

The company's actions reflect the challenges faced by small-cap companies in raising capital and maintaining listing compliance, particularly in the current economic environment. The reliance on convertible notes and warrants is a common strategy for companies seeking funding, but it can lead to significant dilution for existing shareholders.

Comparison to Industry Standards

• The use of convertible notes and warrants for financing is common among small-cap companies, particularly those in the technology and healthcare sectors, such as SCWorx.
• The potential for significant dilution is a typical risk associated with these types of financings, and investors often compare the terms of these deals to similar transactions by comparable companies.
• The proposed reverse stock split is a common measure for companies facing delisting from Nasdaq, and the proposed ratio of 1/2 to 1/15 is within the typical range for such actions.
• Companies like SCWorx, which are in the early stages of growth, often face challenges in raising capital and maintaining listing compliance, and their actions are often compared to similar companies in the same stage of development.

Management Changes

Legal Proceedings

• The company settled a demand for arbitration with Core IR by issuing shares of common stock.

Related Party Transactions

• The company had amounts due to officers of $149,838 and $153,838 at December 31, 2023 and 2022, respectively.
• The company's former CEO advanced $100,000 in cash to the company for short-term capital requirements.
• The company's CFO advanced an aggregate of $193,558 in cash to the company for short-term capital requirements, which has since been repaid.

Stakeholder Impact

• Existing shareholders will experience significant dilution of their ownership.
• The company's employees may be affected by the company's financial situation.
• The company's creditors may be affected by the company's ability to repay its debts.
• The company's customers may be affected by the company's ability to continue operations.

Next Steps

• Stockholders will vote on the proposals at the annual meeting on December 23, 2024.
• The company will proceed with the share issuances if approved by stockholders.
• The company will file a resale registration statement with the SEC.
• The company may implement a reverse stock split if necessary to maintain Nasdaq listing compliance.
• The company plans to execute a second offering of convertible notes and warrants within 60 days of the annual meeting.

Key Dates

Keywords

stockholder meeting, share issuance, convertible notes, warrants, reverse stock split, Nasdaq listing, dilution, capital raise, settlement agreement, private investment